Our results showed that treatment of TGF-β1 to starved NIH3T3 cells in the mixed xenograft tumor could increase the expression of both CAFs markers, while 3-MA treatment reduced the effects of TGF-β1 (Figure 7A and 7B). Here, TGFB1 is linked to neoplasm.